Filter Clotting with Continuous Renal Replacement Therapy in COVID-19

Mostrar otras versiones (1)

Background: Coronavirus disease 2019 (COVID-19) appears to be associated with increased arterial and venous thromboembolic disease. These presumed abnormalities in hemostasis have been associated with filter clotting during continuous renal replacement therapy (CRRT). The incidence, clinical feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosovsky, Rachel P., Endres, Paul, Zhao, Soophia H, Krinsky, Scott, Percy, Shananssa G, Kamal, Omer, Roberts, Russel J., Lopez, Natasha, Sise, Meghan E, Steele, David J, Lundquist, Andrew L, Rhee, Eugene P, Hibbert, Kathryn A, Hardin, Charles C, McCausland, Finnian R, Czarnecki, Peter G., Mutter, Walter P, Tolkoff-Rubin, Nina E, Allegretti, Andrew S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330291/
http://dx.doi.org/10.1182/blood-2020-142106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330291/
http://dx.doi.org/10.1182/blood-2020-142106

Ejemplares similares